Effect of Toll-like Receptor 4 on Cardiac Hypertrophy in Hypertension
Toll样受体4对高血压心肌肥厚的影响
基本信息
- 批准号:18590776
- 负责人:
- 金额:$ 2.42万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We investigated the role of Toll-like receptor 4 (TLR4) in cardiac hypertrophy and function following angiotensin II (Ang II) or norepinephrine (NE) -induced pressure overload in mice in vivo.TLR4-knocked out mice, and wild-type (WT) genetic background mice (BALB/c) were randomized into two groups and implanted osmotic minipumps of Angiotensin II (AT II) or Norepinephrine (NE) for 2 weeks. Both Ang II and NE induced a significant increase in systolic blood pressures among the four groups (p<0.05), while blood pressures and heart rates were not significantly different among the four groups throughout the experiments. Compared with Ang II -induced pressure overload WT mice, Ang II-induced pressure overload TLR4-knockout mice showed a significant increase in both ejection fraction (EF) and % fractional shortening (%FS) (p<0.05), and also demonstrated a smaller left ventricular end-systolic dimension (LVESd, p<0.05). In contrast, compared with NE-induced pressure overload WT mice, NE-induced pressure overload TLR4-knockout mice showed smaller LVESd and an increase in EF and %FS; these indices, however, did not reach statistical significance. Left ventricular end-diastolic dimension, interventricular septum, left ventricular diastolic wall thickness, and heart weight did not differ among the four groups. Compared with Ang II-induced pressure overload WT mice, Ang II-induced pressure overload TLR4-knockout mice showed a significant increase in both perivascular collagen volume fraction (p<0.05), and wall-to-lumen ratio (p<0.05). These results suggest that TLR4 may be involved in the development of Ang II-induced cardiac systolic dysfunction without affecting cardiac hypertrophy.
为了探讨Toll样受体4(TLR4)在血管紧张素II(Ang II)或去甲肾上腺素(NE)诱导的压力超负荷后心肌肥大和功能中的作用。将TLR4基因敲除的小鼠和野生型(WT)遗传背景小鼠(BALB/c)随机分为两组,分别植入血管紧张素II(AT II)或去甲肾上腺素(NE)渗透压微泵2周。血管紧张素II和去甲肾上腺素均使四组大鼠的收缩压显著升高(p<;0.05),而在整个实验过程中,四组大鼠的血压和心率无显著差异。与Ang II诱导的压力超负荷WT小鼠相比,Ang II诱导的压力超负荷TLR4基因敲除小鼠的射血分数(EF)和短轴缩短率(%FS)均显著增加(p<;0.05),且左心室收缩末期内径(LVESd,p<;0.05)明显减小。相反,与去甲肾上腺素诱导的压力超负荷WT小鼠相比,去甲肾上腺素诱导的压力超负荷TLR4基因敲除小鼠的LVESd较小,EF和%FS增加,但这些指标均未达到统计学意义。四组间左室舒张末期内径、室间隔、左室舒张期壁厚度和心脏重量无差异。与Ang II诱导的压力超负荷WT小鼠相比,Ang II诱导的压力超负荷TLR4基因敲除小鼠血管周围胶原体积分数(p<;0.05)和管腔比(p<;0.05)均显著增加。这些结果提示,TLR4可能参与了Ang II诱导的心脏收缩功能障碍的发生,但不影响心肌肥厚。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Comparative effects of pitavastatin and probucol on oxidative stress, Cu/Zn superoxide dismutase, PPARγ, and aortic stiffnessin hypercholesterolemia.
匹伐他汀和普罗布考对高胆固醇血症氧化应激、铜/锌超氧化物歧化酶、PPARγ和主动脉僵硬度的比较影响。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Honjo;H;本荘晴朗 他;Seiji Umemoto;Kyoko Umeji
- 通讯作者:Kyoko Umeji
Effect of Toll-like Receptor 4 0n Cardiac Hypertrophy and Function in Angiotensin II-induced Hypertension
Toll样受体4 0n对血管紧张素II性高血压心肌肥厚及功能的影响
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Yoshino;H;吉野 敬子
- 通讯作者:吉野 敬子
高血圧性心肥大形成過程におけるToll-Like Receptor 4の役割
Toll样受体4在高血压心肌肥厚形成过程中的作用
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Yoshino;H;吉野 敬子;吉野敬子
- 通讯作者:吉野敬子
Calcium antagonist inhibits vascular remodeling by reducing oxidative stress through upregulation of Cu/Zn superoxide dismutase via peroxysome proliferator activated receptor γ in hearts of stroke-prone spontaneously hypertensive rats
钙拮抗剂通过过氧化物酶体增殖物激活受体γ上调铜/锌超氧化物歧化酶,减少易发生中风的自发性高血压大鼠心脏的氧化应激,从而抑制血管重塑
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Umemoto;S;吉野 敬子;吉野 敬子;吉野 敬子;梅本 誠治;Shinichi Itoh;Masunori Mtsuzaki;Ryo Hashimoto;Ryo Hashimoto
- 通讯作者:Ryo Hashimoto
Low dose nifedipine inhibits vascular remodeling and improves vascular function through Cu/ZnSOD via PPARγ in hypertension in vivo
小剂量硝苯地平通过 Cu/ZnSOD 通过 PPARγ 抑制高血压体内血管重塑并改善血管功能
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Umemoto;S;吉野 敬子;吉野 敬子;吉野 敬子;梅本 誠治
- 通讯作者:梅本 誠治
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
UMEMOTO Seiji其他文献
UMEMOTO Seiji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('UMEMOTO Seiji', 18)}}的其他基金
New mechanisms for organ damage elucidated by oxidative stress associated with innate immunity
与先天免疫相关的氧化应激阐明了器官损伤的新机制
- 批准号:
24591115 - 财政年份:2012
- 资助金额:
$ 2.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
New Mechanisms of the Protection against the Increase in Oxidative Stress in Hypertension
预防高血压氧化应激增加的新机制
- 批准号:
21590954 - 财政年份:2009
- 资助金额:
$ 2.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
The Injectrode- An injectable, easily removable electrode as a trial lead for baroreceptor activation therapy to treat hypertension and heart failure
Injectrode——一种可注射、易于拆卸的电极,作为压力感受器激活疗法的试验引线,以治疗高血压和心力衰竭
- 批准号:
10697600 - 财政年份:2023
- 资助金额:
$ 2.42万 - 项目类别:
Bedside right-heart catheterization for early diagnosis and more effective management of patients with heart failure and primary pulmonary hypertension
床边右心导管检查可对心力衰竭和原发性肺动脉高压患者进行早期诊断和更有效的治疗
- 批准号:
10696663 - 财政年份:2023
- 资助金额:
$ 2.42万 - 项目类别:
A non-invasive, automated platform for hemodynamic assessment of patients at risk of heart failure or pulmonary hypertension
用于对有心力衰竭或肺动脉高压风险的患者进行血流动力学评估的无创自动化平台
- 批准号:
10699067 - 财政年份:2023
- 资助金额:
$ 2.42万 - 项目类别:
Effect of Dietary Approaches to Stop Hypertension (DASH) Diet on Heart Failure Status in Older Adults
降血压饮食方法 (DASH) 饮食对老年人心力衰竭状况的影响
- 批准号:
10666118 - 财政年份:2023
- 资助金额:
$ 2.42万 - 项目类别:
Telephone-based mindfulness training to reduce blood pressure in Black women with hypertension in the Jackson Heart Study
杰克逊心脏研究中基于电话的正念训练可降低患有高血压的黑人女性的血压
- 批准号:
10678779 - 财政年份:2022
- 资助金额:
$ 2.42万 - 项目类别:
The Pathophysiological Factors Driving Diastolic Dysfunction of the Right Heart in Pulmonary Hypertension
肺动脉高压右心舒张功能障碍的病理生理因素
- 批准号:
22K15368 - 财政年份:2022
- 资助金额:
$ 2.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Telephone-based mindfulness training to reduce blood pressure in Black women with hypertension in the Jackson Heart Study
杰克逊心脏研究中基于电话的正念训练可降低患有高血压的黑人女性的血压
- 批准号:
10446530 - 财政年份:2022
- 资助金额:
$ 2.42万 - 项目类别:
A Pathogenic Role for Natriuretic Peptide Receptor-C in Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction
钠尿肽受体-C 在肺动脉高压和射血分数保留的心力衰竭中的致病作用
- 批准号:
10463813 - 财政年份:2021
- 资助金额:
$ 2.42万 - 项目类别:
Determining true versus apparent treatment-resistant hypertension among African Americans in the Jackson Heart Study
杰克逊心脏研究中确定非裔美国人真实与明显的难治性高血压
- 批准号:
10280668 - 财政年份:2021
- 资助金额:
$ 2.42万 - 项目类别: